Helen of Troy [HELE] vs Procter & Gamble [PG] Detailed Stock Comparison
Helen of Troy
NASDAQ
Loading...
Procter & Gamble
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Helen of Troy wins in 7 metrics, Procter & Gamble wins in 12 metrics, with 0 ties. Procter & Gamble appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Helen of Troy | Procter & Gamble | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 4.46 | 24.58 | Helen of Troy |
| Price-to-Book Ratio | 0.48 | 7.31 | Helen of Troy |
| Debt-to-Equity Ratio | 74.29 | 69.86 | Procter & Gamble |
| PEG Ratio | 0.00 | 21.57 | Helen of Troy |
| EV/EBITDA | 6.04 | 16.47 | Helen of Troy |
| Profit Margin (TTM) | -17.89% | 18.95% | Procter & Gamble |
| Operating Margin (TTM) | 1.52% | 25.15% | Procter & Gamble |
| EBITDA Margin (TTM) | 1.52% | 25.15% | Procter & Gamble |
| Return on Equity | -23.99% | 31.24% | Procter & Gamble |
| Return on Assets (TTM) | 4.30% | 10.91% | Procter & Gamble |
| Free Cash Flow (TTM) | $83.14M | $14.04B | Procter & Gamble |
| Dividend Yield | N/A | 1.92% | N/A |
| 1-Year Return | -53.36% | -8.87% | Procter & Gamble |
| Price-to-Sales Ratio (TTM) | 0.32 | 4.45 | Helen of Troy |
| Enterprise Value | $1.47B | $402.85B | Procter & Gamble |
| EV/Revenue Ratio | 0.79 | 4.78 | Helen of Troy |
| Gross Profit Margin (TTM) | 47.09% | 49.11% | Procter & Gamble |
| Revenue per Share (TTM) | $81 | $36 | Helen of Troy |
| Earnings per Share (Diluted) | $-14.54 | $6.51 | Procter & Gamble |
| Beta (Stock Volatility) | 0.84 | 0.36 | Procter & Gamble |
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends
Helen of Troy vs Procter & Gamble Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Helen of Troy | -3.99% | 4.15% | 12.40% | -8.48% | -53.59% | -57.05% |
| Procter & Gamble | -0.62% | 1.90% | 6.32% | -1.71% | -8.36% | -3.59% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Helen of Troy | -53.36% | -79.00% | -87.01% | -70.78% | 4.50% | 14.87% |
| Procter & Gamble | -8.87% | 14.33% | 15.84% | 133.88% | 164.93% | 181.23% |
News Based Sentiment: Helen of Troy vs Procter & Gamble
Helen of Troy
News based Sentiment: MIXED
The month featured a significant shift in investor sentiment with a major short position being closed, coupled with a new CEO appointment. However, analyst opinions remain divided, and the company's performance still needs to be validated by the upcoming earnings report, creating a mixed investment picture.
Procter & Gamble
News based Sentiment: MIXED
P&G reported strong Q4 earnings but issued cautious guidance for 2026 due to cost headwinds. While the company continues to return capital to shareholders and invest in growth initiatives like e-commerce, mixed analyst sentiment and planned job cuts create uncertainty. This makes September a month of both positive and negative developments for investors.
Performance & Financial Health Analysis: Helen of Troy vs Procter & Gamble
| Metric | HELE | PG |
|---|---|---|
| Market Information | ||
| Market Cap | $605.08M | $374.83B |
| Market Cap Category | Small cap | Mega cap |
| 10 Day Avg. Volume | 684,770 | 5,895,030 |
| 90 Day Avg. Volume | 651,513 | 7,030,250 |
| Last Close | $24.55 | $159.03 |
| 52 Week Range | $20.02 - $77.95 | $149.91 - $180.43 |
| % from 52W High | -68.51% | -11.86% |
| All-Time High | $265.97 (Jan 25, 2021) | $180.43 (Nov 25, 2024) |
| % from All-Time High | -90.77% | -11.86% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.11% | 0.02% |
| Quarterly Earnings Growth | -0.11% | 0.15% |
| Financial Health | ||
| Profit Margin (TTM) | -0.18% | 0.19% |
| Operating Margin (TTM) | 0.02% | 0.25% |
| Return on Equity (TTM) | -0.24% | 0.31% |
| Debt to Equity (MRQ) | 74.29 | 69.86 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $53.51 | $21.88 |
| Cash per Share (MRQ) | $1.17 | $4.08 |
| Operating Cash Flow (TTM) | $146.23M | $17.82B |
| Levered Free Cash Flow (TTM) | $168.35M | $11.38B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 1.92% |
| Last 12-Month Dividend | N/A | $3.03 |
Valuation & Enterprise Metrics Analysis: Helen of Troy vs Procter & Gamble
| Metric | HELE | PG |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 4.46 | 24.58 |
| Forward P/E | 3.24 | 21.57 |
| PEG Ratio | 0.00 | 21.57 |
| Price to Sales (TTM) | 0.32 | 4.45 |
| Price to Book (MRQ) | 0.48 | 7.31 |
| Market Capitalization | ||
| Market Capitalization | $605.08M | $374.83B |
| Enterprise Value | $1.47B | $402.85B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 0.79 | 4.78 |
| Enterprise to EBITDA | 6.04 | 16.47 |
| Risk & Other Metrics | ||
| Beta | 0.84 | 0.36 |
| Book Value per Share (MRQ) | $53.51 | $21.88 |
Financial Statements Comparison: Helen of Troy vs Procter & Gamble
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | HELE | PG |
|---|---|---|
| Revenue/Sales | $371.66M | $20.89B |
| Cost of Goods Sold | $196.64M | $10.63B |
| Gross Profit | $175.01M | $10.26B |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | N/A | $4.35B |
| EBITDA | $21.74M | $5.46B |
| Pre-Tax Income | $-420.54M | $4.52B |
| Income Tax | $30.18M | $895.00M |
| Net Income (Profit) | $-450.72M | $3.63B |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | HELE | PG |
|---|---|---|
| Cash & Equivalents | $22.67M | $9.56B |
| Total Current Assets | $855.42M | $25.39B |
| Total Current Liabilities | $504.51M | $36.06B |
| Long-Term Debt | $891.70M | $25.70B |
| Total Shareholders Equity | $1.23B | $52.28B |
| Retained Earnings | $861.05M | $129.97B |
| Property, Plant & Equipment | $576.16M | $0 |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | HELE | PG |
|---|---|---|
| Operating Cash Flow | $-413.83M | $3.71B |
| Capital Expenditures | $46,000 | N/A |
| Free Cash Flow | $44.98M | $2.85B |
| Debt Repayment | $-426.54M | $-1.05B |
| Common Stock Repurchase | $-1.33M | $-1.35B |
Short Interest & Institutional Ownership Analysis
| Metric | HELE | PG |
|---|---|---|
| Shares Short | 3.13M | 16.72M |
| Short Ratio | 3.50 | 2.21 |
| Short % of Float | 0.22% | 0.01% |
| Average Daily Volume (10 Day) | 684,770 | 5,895,030 |
| Average Daily Volume (90 Day) | 651,513 | 7,030,250 |
| Shares Outstanding | 22.86M | 2.34B |
| Float Shares | 22.35M | 2.34B |
| % Held by Insiders | 0.01% | 0.00% |
| % Held by Institutions | 1.06% | 0.70% |
Dividend Analysis & Yield Comparison: Helen of Troy vs Procter & Gamble
| Metric | HELE | PG |
|---|---|---|
| Last 12-Month Dividend | N/A | $3.03 |
| Last 12-Month Dividend Yield | N/A | 1.92% |
| 3-Year Avg Annual Dividend | N/A | $3.51 |
| 3-Year Avg Dividend Yield | N/A | 0.63% |
| 3-Year Total Dividends | N/A | $10.53 |
| Ex-Dividend Date | N/A | Jan 24, 2025 |